StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) PT Raised to $142 at Stifel on 3Q Earnings Report; 'Pharma Carries the Day, Hurricane Headwinds Encouragingly Modest
October 17, 2017 5:16 PM
Stifel raised its price target on Johnson & Johnson (NYSE: JNJ) to $142.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Johnson & Johnson (JNJ) Declares $0.84 Quarterly Dividend; 2.4% Yield
October 19, 2017 6:55 AM
Johnson & Johnson (JNJ) PT Raised to $145 at Morgan Stanley
October 18, 2017 7:49 AM
Johnson & Johnson (JNJ) PT Raised to $161 at Jefferies
October 18, 2017 7:30 AM
Johnson & Johnson (JNJ) PT Raised to $165 at Leerink Partners
October 18, 2017 7:03 AM
Johnson & Johnson (JNJ) Wins Reversal of First St. Louis Talc-Cancer Verdict - Bloomberg
October 17, 2017 12:00 PM
Johnson & Johnson (JNJ) Tops Q3 EPS by 10c; Raises Outlook
October 17, 2017 6:42 AM
Johnson & Johnson (JNJ) PT Raised to $160 at Jefferies
October 16, 2017 6:44 AM
Janssen (JNJ) Announces U.S. FDA Approval Of STELARA For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
October 13, 2017 4:21 PM
Meeting highlights from CHMP 9-12 October 2017
October 13, 2017 7:54 AM
